Paper42881185PubMed
Next-generation natural killer cell therapy: bench to bedside and beyond.
Zhao A and 9 others. Signal Transduct Target Ther, 2026.
Cite this record
ConductScience Library. Next-generation natural killer cell therapy: bench to bedside and beyond. Papers, record 42881185. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42881185
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Next-generation natural killer cell therapy: bench to bedside and beyond.
- Journal
- Signal Transduct Target Ther
- Year
- 2026
- Publication types
- Journal Article, Review, Research Support, Non-U.S. Gov't
- Revised in PubMed
- 2026-10-20
Source PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Killer Cells, Natural | Major topic |
| Neoplasms | Major topic |
| Receptors, Chimeric Antigen | Major topic |
| Immunotherapy, Adoptive | Major topic |
| Humans | |
| Animals |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| LTGY24H080001 | Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) | PubMed |
Source PubMed
References462
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20444980 | Rapid lytic granule convergence to the MTOC in natural killer cells is dependent on dynein but not cytolytic commitment. | Mol Biol Cell | 2010 | https://conductscience.org/library/papers/20444980 | PubMed |
| 2 | 27775550 | MicroRNA-29b mediates altered innate immune development in acute leukemia. | J Clin Invest | 2016 | https://conductscience.org/library/papers/27775550 | PubMed |
| 3 | 37391486 | Inserting EF1α-driven CD7-specific CAR at CD7 locus reduces fratricide and enhances tumor rejection. | Leukemia | 2023 | https://conductscience.org/library/papers/37391486 | PubMed |
| 4 | 22493516 | Proinflammatory cytokine signaling required for the generation of natural killer cell memory. | J Exp Med | 2012 | https://conductscience.org/library/papers/22493516 | PubMed |
| 5 | 37828009 | Perinatal murine cytomegalovirus infection reshapes the transcriptional profile and functionality of NK cells. | Nat Commun | 2023 | https://conductscience.org/library/papers/37828009 | PubMed |
| 6 | 35027451 | PDGF-D-PDGFRβ signaling enhances IL-15-mediated human natural killer cell survival. | Proc Natl Acad Sci U S A | 2022 | https://conductscience.org/library/papers/35027451 | PubMed |
| 7 | 25939063 | 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors. | Nat Med | 2015 | https://conductscience.org/library/papers/25939063 | PubMed |
| 8 | 32826231 | Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for Leukemia. | Cancer Discov | 2020 | https://conductscience.org/library/papers/32826231 | PubMed |
| 9 | 38238616 | Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial. | Nat Med | 2024 | https://conductscience.org/library/papers/38238616 | PubMed |
| 10 | 40119192 | Enhancing human NK cell antitumor function by knocking out SMAD4 to counteract TGFβ and activin A suppression. | Nat Immunol | 2025 | https://conductscience.org/library/papers/40119192 | PubMed |
| 11 | 17320507 | Chromatin modifications and their function. | Cell | 2007 | https://conductscience.org/library/papers/17320507 | PubMed |
| 12 | 37074304 | Deficits in our understanding of natural killer cell development in mouse and human. | Curr Opin Hematol | 2023 | https://conductscience.org/library/papers/37074304 | PubMed |
| 13 | 21173117 | Natural killer-cell differentiation by myeloid progenitors. | Blood | 2011 | https://conductscience.org/library/papers/21173117 | PubMed |
| 14 | 37117524 | Senolytic vaccination improves normal and pathological age-related phenotypes and increases lifespan in progeroid mice. | Nat Aging | 2021 | https://conductscience.org/library/papers/37117524 | PubMed |
| 15 | 30082830 | Epigenetic control of innate and adaptive immune memory. | Nat Immunol | 2018 | https://conductscience.org/library/papers/30082830 | PubMed |
| 16 | 26873994 | Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells. | J Immunol | 2016 | https://conductscience.org/library/papers/26873994 | PubMed |
| 17 | 18097043 | Lineage-specific transition of histone signatures in the killer cell Ig-like receptor locus from hematopoietic progenitor to NK cells. | J Immunol | 2008 | https://conductscience.org/library/papers/18097043 | PubMed |
| 18 | 38890285 | The miR-29 family facilitates the activation of NK-cell immune responses by targeting the B7-H3 immune checkpoint in neuroblastoma. | Cell Death Dis | 2024 | https://conductscience.org/library/papers/38890285 | PubMed |
| 19 | 36706761 | Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance. | Cancer Cell | 2023 | https://conductscience.org/library/papers/36706761 | PubMed |
| 20 | 26697006 | Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy. | Front Immunol | 2015 | https://conductscience.org/library/papers/26697006 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42881185
GET https://conductscience.org/api/papers/v1/42881185/references?page=2